HAL (France)open access
Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates
Microvascular complications, Fibrates, Metabolic dysfunction-associated steatotic liver disease, Fenofibrate, 0, Cardiovascular-kidney-liver-metabolic syndrome, Cardiovascular-kidney-liver-metabolic syndrome fenofibrate fibrates metabolic dysfunction-associated steatotic liver disease microvascular complications type 2 diabetes mellitus, Type 2 diabetes mellitus
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 624957
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.